Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven J Coats

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Journal of Medicinal Chemistry|November 4, 2014
Asymmetric binding to NS5A by daclatasvir (BMS-790052) and analogs suggests two novel modes of HCV inhibitionJames H Nettles, Richard A Stanton, Joshua Broyde, et al.
Bioorganic & Medicinal Chemistry Letters|October 19, 2013
Azetidines and spiro azetidines as novel P2 units in hepatitis C virus NS3 protease inhibitorsLavanya Bondada, Ramu Rondla, Ugo Pradere, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 2004
Parallel methods for the preparation and SAR exploration of N-ethyl-4-[(8-alkyl-8-aza-bicyclo[3.2.1]oct-3-ylidene)-aryl-methyl]-benzamides, powerful mu and delta opioid agonistsSteven J Coats, Mark J Schulz, John R Carson, et al.
Bioorganic & Medicinal Chemistry Letters|April 21, 2009
Triazinediones as prokineticin 1 receptor antagonists. Part 1: SAR, synthesis and biological evaluationJanet L Ralbovsky, Joseph G Lisko, Jeffrey M Palmer, et al.
Antimicrobial Agents and Chemotherapy|July 15, 2009
Anti-human immunodeficiency virus activity, cross-resistance, cytotoxicity, and intracellular pharmacology of the 3'-azido-2',3'-dideoxypurine nucleosidesNicolas Sluis-Cremer, Dianna Koontz, Leda Bassit, et al.
Bioorganic & Medicinal Chemistry Letters|December 2, 2009
Synthesis and evaluation of 3'-azido-2',3'-dideoxypurine nucleosides as inhibitors of human immunodeficiency virusHong-Wang Zhang, Steven J Coats, Lavanya Bondada, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2004
N-alkyl-4-[(8-azabicyclo[3.2.1]-oct-3-ylidene)phenylmethyl]benzamides, micro and delta opioid agonists: a micro addressJohn R Carson, Steven J Coats, Ellen E Codd, et al.
European Journal of Medicinal Chemistry|June 25, 2011
Synthesis, antiviral activity, cytotoxicity and cellular pharmacology of l-3'-azido-2',3'-dideoxypurine nucleosidesHong-Wang Zhang, Mervi Detorio, Brian D Herman, et al.
Antimicrobial Agents and Chemotherapy|June 1, 2017
Nucleotide Substrate Specificity of Anti-Hepatitis C Virus Nucleoside Analogs for Human Mitochondrial RNA PolymeraseMaryam Ehteshami, Longhu Zhou, Sheida Amiralaei, et al.
Journal of Medicinal Chemistry|April 8, 2015
β-D-2'-C-Methyl-2,6-diaminopurine Ribonucleoside Phosphoramidates are Potent and Selective Inhibitors of Hepatitis C Virus (HCV) and Are Bioconverted Intracellularly to Bioactive 2,6-Diaminopurine and Guanosine 5'-Triphosphate FormsLonghu Zhou, Hong-wang Zhang, Sijia Tao, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Journal of Medicinal Chemistry|November 4, 2014
Asymmetric binding to NS5A by daclatasvir (BMS-790052) and analogs suggests two novel modes of HCV inhibitionJames H Nettles, Richard A Stanton, Joshua Broyde, et al.
Bioorganic & Medicinal Chemistry Letters|October 19, 2013
Azetidines and spiro azetidines as novel P2 units in hepatitis C virus NS3 protease inhibitorsLavanya Bondada, Ramu Rondla, Ugo Pradere, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 2004
Parallel methods for the preparation and SAR exploration of N-ethyl-4-[(8-alkyl-8-aza-bicyclo[3.2.1]oct-3-ylidene)-aryl-methyl]-benzamides, powerful mu and delta opioid agonistsSteven J Coats, Mark J Schulz, John R Carson, et al.
Bioorganic & Medicinal Chemistry Letters|April 21, 2009
Triazinediones as prokineticin 1 receptor antagonists. Part 1: SAR, synthesis and biological evaluationJanet L Ralbovsky, Joseph G Lisko, Jeffrey M Palmer, et al.
Antimicrobial Agents and Chemotherapy|July 15, 2009
Anti-human immunodeficiency virus activity, cross-resistance, cytotoxicity, and intracellular pharmacology of the 3'-azido-2',3'-dideoxypurine nucleosidesNicolas Sluis-Cremer, Dianna Koontz, Leda Bassit, et al.
Bioorganic & Medicinal Chemistry Letters|December 2, 2009
Synthesis and evaluation of 3'-azido-2',3'-dideoxypurine nucleosides as inhibitors of human immunodeficiency virusHong-Wang Zhang, Steven J Coats, Lavanya Bondada, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2004
N-alkyl-4-[(8-azabicyclo[3.2.1]-oct-3-ylidene)phenylmethyl]benzamides, micro and delta opioid agonists: a micro addressJohn R Carson, Steven J Coats, Ellen E Codd, et al.
European Journal of Medicinal Chemistry|June 25, 2011
Synthesis, antiviral activity, cytotoxicity and cellular pharmacology of l-3'-azido-2',3'-dideoxypurine nucleosidesHong-Wang Zhang, Mervi Detorio, Brian D Herman, et al.
Antimicrobial Agents and Chemotherapy|June 1, 2017
Nucleotide Substrate Specificity of Anti-Hepatitis C Virus Nucleoside Analogs for Human Mitochondrial RNA PolymeraseMaryam Ehteshami, Longhu Zhou, Sheida Amiralaei, et al.
Journal of Medicinal Chemistry|April 8, 2015
β-D-2'-C-Methyl-2,6-diaminopurine Ribonucleoside Phosphoramidates are Potent and Selective Inhibitors of Hepatitis C Virus (HCV) and Are Bioconverted Intracellularly to Bioactive 2,6-Diaminopurine and Guanosine 5'-Triphosphate FormsLonghu Zhou, Hong-wang Zhang, Sijia Tao, et al.
Pageof 6